J Korean Neurosurg Soc.  2024 Jul;67(4):451-457. 10.3340/jkns.2023.0176.

Protein Requirement Changes According to the Treatment Application in Neurocritical Patients

Affiliations
  • 1Department of Traumatology, Gachon University Gil Medical Center, Incheon, Korea
  • 2Department of Critical Care Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 3Department of Neurosurgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 4Department of Neurosurgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
  • 5SMG-SNU Boramae Medical Center, Seoul, Korea
  • 6Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea
  • 7Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea

Abstract


Objective
: Exploring protein requirements for critically ill patients has become prominent. On the other hand, considering the significant impact of coma therapy and targeted temperature management (TTM) on the brain as well as systemic metabolisms, protein requirements may plausibly be changed by treatment application. However, there is currently no research on protein requirements following the application of these treatments. Therefore, the aim of this study is to elucidate changes in patients’ protein requirements during the application of TTM and coma therapy.
Methods
: This study is a retrospective analysis of prospectively collected data from March 2019 to May 2022. Among the patients admitted to the intensive care unit, those receiving coma therapy and TTM were included. The patient’s treatment period was divided into two phases (phase 1, application and maintenance of coma therapy and TTM; phase 2, tapering and cessation of treatment). In assessing protein requirements, the urine urea nitrogen (UUN) method was employed to estimate the nitrogen balance, offering insight into protein utilization within the body. The patient’s protein requirement for each phase was defined as the amount of protein required to achieve a nitrogen balance within ±5, based on the 24-hour collection of UUN. Changes in protein requirements between phases were analyzed.
Results
: Out of 195 patients, 107 patients with a total of 214 UUN values were included. The mean protein requirement for the entire treatment period was 1.84±0.62 g/kg/day, which is higher than the generally recommended protein supply of 1.2 g/kg/day. As the treatment was tapered, there was a statistically significant increase in the protein requirement from 1.49±0.42 to 2.18±0.60 in phase 2 (p<0.001).
Conclusion
: Our study revealed a total average protein requirement of 1.84±0.62 g during the treatment period, which falls within the upper range of the preexisting guidelines. Nevertheless, a notable deviation emerged when analyzing the treatment application period separately. Hence, it is recommended to incorporate considerations for the type and timing of treatment, extending beyond the current guideline, which solely accounts for the severity by disease.

Keyword

Neurocritical care; Protein requirement; Nitrogen balance; Nutrition support; Urine urea nitrogen

Figure

  • Fig. 1. Protein requirements according to neurocritical treatment phases. During the active implementation of targeted temperature management and coma therapy in phase 1, the protein requirement was 1.49±0.42 g/kg/day. However, in phase 2, as the intensive treatment was tapered, it increased to 2.18±0.60 g/kg/day (****p<0.0001). The unit of measurement is g/kg/day.

  • Fig. 2. Subgroup analyses of protein requirements based on specific diagnoses. In all subgroup analyses, the trends in phases 1 and 2 were consistent with those observed in the overall patient population. The unit of measurement is g/kg/day (***p<0.001, ****p<0.0001). TBI : traumatic brain injury, SAH : subarachnoid hemorrhage, ICH : intracerebral hemorrhage.


Cited by  1 articles

Editors’ Pick in July 2024
Hee-Jin Yang
J Korean Neurosurg Soc. 2024;67(4):383-384.    doi: 10.3340/jkns.2024.0119.


Reference

References

1. Ashcraft CM, Frankenfield DC. Energy expenditure during barbiturate coma. Nutr Clin Pract. 28:603–608. 2013.
Article
2. Badjatia N, Monahan A, Carpenter A, Zimmerman J, Schmidt JM, Claassen J, et al. Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology. 84:680–687. 2015.
Article
3. Bidkar PU. Nutrition in neuro-intensive care and outcomes. J Neuroanaesth Crit Care. 3:S70–S76. 2016.
Article
4. Bingham SA. Urine nitrogen as a biomarker for the validation of dietary protein intake. J Nutr 133 Suppl. 3:921S–924S. 2003.
Article
5. Bourke CD, Berkley JA, Prendergast AJ. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 37:386–398. 2016.
Article
6. Buckley CT, Dickerson RN. Propofol: a risk factor for caloric overfeeding and inadequate protein delivery. Hosp Pharm. 55:151–152. 2020.
Article
7. Chapple LA, Chapman MJ, Lange K, Deane AM, Heyland DK. Nutrition support practices in critically ill head-injured patients: a global perspective. Crit Care. 20:6. 2016.
Article
8. Compher C, Bingham AL, McCall M, Patel J, Rice TW, Braunschweig C, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 46:12–41. 2022.
Article
9. Dickerson RN, Roth-Yousey L. Medication effects on metabolic rate: a systematic review (part 1). J Am Diet Assoc. 105:835–843. 2005.
Article
10. Erecinska M, Thoresen M, Silver IA. Effects of hypothermia on energy metabolism in Mammalian central nervous system. J Cereb Blood Flow Metab. 23:513–530. 2003.
Article
11. Fan E, Ciesla ND, Truong AD, Bhoopathi V, Zeger SL, Needham DM. Inter-rater reliability of manual muscle strength testing in ICU survivors and simulated patients. Intensive Care Med. 36:1038–1043. 2010.
Article
12. Fisher N, Uhler ME : Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Philadelphia : Lippincott Williams & Wilkins, 1999.
13. Fuhrman FA. The effect of body temperature on the duration of barbiturate anesthesia in mice. Science. 105:387–388. 1947.
Article
14. Heyland DK, Mourtzakis M : Malnutrition in Critical Illness: Implications, Causes, and Therapeutic Approaches in Stevens RD, Hart N, Herridge MS (eds) : Textbook of Post-ICU Medicine: The Legacy of Critical Care. Oxford : Oxford University Press, 2014, pp.401-416.
15. Heyland DK, Weijs PJ, Coss‐Bu JA, Taylor B, Kristof AS, O’Keefe GE, et al. Protein delivery in the intensive care unit: optimal or suboptimal? Nutr Clin Pract. 32:58S–71S. 2017.
Article
16. Ingadottir AR, Beck AM, Baldwin C, Weekes CE, Geirsdottir OG, Ramel A, et al. Association of energy and protein intakes with length of stay, readmission and mortality in hospitalised patients with chronic obstructive pulmonary disease. Br J Nutr. 119:543–551. 2018.
Article
17. Lee HY, Oh BM. Nutrition management in patients with traumatic brain injury: a narrative review. Brain Neurorehabil. 15:e4. 2022.
Article
18. McCall M, Jeejeebhoy K, Pencharz P, Moulton R. Effect of neuromuscular blockade on energy expenditure in patients with severe head injury. JPEN J Parenter Enteral Nutr. 27:27–35. 2003.
Article
19. McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 40:159–211. 2016.
Article
20. Mogensen KM, Robinson MK, Casey JD, Gunasekera NS, Moromizato T, Rawn JD, et al. Nutritional status and mortality in the critically ill. Crit Care Med. 43:2605–2615. 2015.
Article
21. Moritz F, Petit J, Kaeffer N, Oksenhendler G, Papion H, Hecketsweiler B, et al. Metabolic effects of propofol and flunitrazepam given for sedation after aortic surgery. Br J Anaesth. 70:451–453. 1993.
Article
22. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 37(7 Suppl):S186–S202. 2009.
Article
23. Sato J, Inaba H, Hirasawa H, Mizuguchi T. Metabolic changes associated with malnutrition in the patients with multiple organ failure. J Anesth. 7:276–286. 1993.
Article
24. Sieber CC. Malnutrition and sarcopenia. Aging Clin Exp Res. 31:793–798. 2019.
Article
25. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 38:48–79. 2019.
Article
26. Stechmiller JK. Understanding the role of nutrition and wound healing. Nutr Clin Pract. 25:61–68. 2010.
Article
27. Tripathy S. Nutrition in the neurocritical care unit. J Neuroanaesth Crit Care. 2:88–96. 2015.
Article
28. Villet S, Chiolero RL, Bollmann MD, Revelly JP, Cayeux R N MC, Delarue J, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 24:502–509. 2005.
Article
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr